His main research concerns Alzheimer's disease, Neuroscience, Genetically modified mouse, Disease and Internal medicine. His studies deal with areas such as Autophagy, Immunology, Phosphorylation, Cognitive decline and Hippocampus as well as Alzheimer's disease. Salvatore Oddo applies his multidisciplinary studies on Neuroscience and Tangle in his research.
His Genetically modified mouse study typically links adjacent topics like Pathology. His Disease research focuses on subjects like Transgene, which are linked to Progressive neurodegenerative disorder, Aβ oligomers, Tau pathology and Fibril. His Internal medicine research incorporates themes from Endocrinology and Effects of sleep deprivation on cognitive performance.
His primary scientific interests are in Neuroscience, Alzheimer's disease, Disease, Genetically modified mouse and Pathology. His Neuroscience research integrates issues from Autophagy, PI3K/AKT/mTOR pathway, Pathogenesis and Cognitive decline. His Alzheimer's disease study integrates concerns from other disciplines, such as Endocrinology, Hippocampus and Amyloid.
The various areas that he examines in his Disease study include Cancer research, Transgenic Model, Microglia, Intracellular and Necroptosis. His Genetically modified mouse research is multidisciplinary, relying on both Phenotype, Frontotemporal lobar degeneration, Tau protein and Endogeny. His Amyloid precursor protein research includes themes of Neuropathology and Phosphorylation, Cell biology.
His primary areas of investigation include Neuroscience, Disease, Pathology, Insulin and Necroptosis. His study brings together the fields of Neurodegeneration and Neuroscience. His study in Disease is interdisciplinary in nature, drawing from both Autophagy, Clinical trial, Transgene, Cognition and Intensive care medicine.
Salvatore Oddo has included themes like Inflammation, Microglia, Choline and Choline chloride in his Pathology study. His Inflammation research integrates issues from Entorhinal cortex, Hippocampus and Genetically modified mouse. His Amyloid course of study focuses on DYRK1A and Pathogenesis, Neurofibrillary tangle, Biochemistry of Alzheimer's disease and Alzheimer's disease.
Salvatore Oddo mostly deals with Pathology, Neuroscience, Transgene, Alzheimer's disease and Amyloid. His work carried out in the field of Pathology brings together such families of science as Autophagy, Schizophrenia and In vivo. His biological study spans a wide range of topics, including mTORC1, PI3K/AKT/mTOR pathway, Neuron death, RAC1 and Disease.
Salvatore Oddo is interested in Genetically modified mouse, which is a branch of Transgene. His Alzheimer's disease research is multidisciplinary, incorporating perspectives in DYRK1A, Amyloid beta and Pathogenesis. His studies in Amyloid integrate themes in fields like Inflammation, Entorhinal cortex and Phosphorylation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham.
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles: Intracellular Aβ and Synaptic Dysfunction
Salvatore Oddo;Antonella Caccamo;Jason D. Shepherd;M. Paul Murphy.
Intracellular amyloid-β in Alzheimer's disease
Frank M. LaFerla;Kim N. Green;Salvatore Oddo.
Nature Reviews Neuroscience (2007)
Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice
Lauren M. Billings;Salvatore Oddo;Kim N. Green;James L. McGaugh.
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
Salvatore Oddo;Antonella Caccamo;Masashi Kitazawa;Bertrand P. Tseng.
Neurobiology of Aging (2003)
Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome
Salvatore Oddo;Lauren Billings;J.Patrick Kesslak;David H. Cribbs.
Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau EFFECTS ON COGNITIVE IMPAIRMENTS
Antonella Caccamo;Smita Majumder;Arlan Richardson;Arlan Richardson;Randy Strong;Randy Strong.
Journal of Biological Chemistry (2010)
Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease
Masashi Kitazawa;Salvatore Oddo;Tritia R. Yamasaki;Kim N. Green.
The Journal of Neuroscience (2005)
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
Robert A. Rissman;Wayne W. Poon;Mathew Blurton-Jones;Salvatore Oddo.
Journal of Clinical Investigation (2004)
Alzheimer's disease: Aβ, tau and synaptic dysfunction
Frank M. LaFerla;Salvatore Oddo.
Trends in Molecular Medicine (2005)
(Impact Factor: 3.61)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: